Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Nexium

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Nexium was produced by AstraZeneca and Daiichi Sankyo.

AstraZeneca’s oncology renaissance

AstraZeneca’s oncology renaissance

This saw phase 3 flops of drugs for stroke, prostate cancer and depression – failures that dented confidence in the firm as patent expiries for its blockbusters Crestor and Nexium loomed on

China: AstraZeneca’s new engine for growth and innovation

China: AstraZeneca’s new engine for growth and innovation years for AZ to return to top-line growth after the patent loss of blockbuster brands such as Nexium and Crestor.

AZ expects return to growth this year after 2017 decline

AZ expects return to growth this year after 2017 decline to $2.6bn, although the cumulative effect of patent expiries - which also affect antipsychotic Seroquel XR (quetiapine) and gastrointestinal drug Nexium (esomeprazole) - are starting to dissipate.

AZ sells Zurampic rights to Gruenenthal for $230m

AZ sells Zurampic rights to Gruenenthal for $230m light of the loss of patent protection for blockbuster brands such as cholesterol drug Crestor (rosuvastatin) and Nexium (esomeprazole) for gastrointestinal diseases.

AZ adds gout drug Zurampic to asset sale

AZ adds gout drug Zurampic to asset sale The deal gives AZ another cash injection as it weathers the loss of blockbuster brands such as cholesterol drug Crestor (rosuvastatin) and Nexium (esomeprazole) for gastrointestinal diseases and brings new pipeline

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics